Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


UCL Advances 5 years celebration

Publication date: Oct 29, 2012 02:21 PM

Start: Nov 26, 2012 06:00 PM
End: Nov 26, 2012 08:00 PM

Location: North Cloisters, Wilkins Building, UCL

[image reference is broken]

After five years of ambitious advancing... we deserve a party!
UCL Advances was formed in 2007. In the five years since we have seen some fantastic achievements, and we are ambitious to build on that success in the future. Please join us to celebrate: 

6-8pm, Monday 26 November 2012
North Cloisters, Wilkins Building, UCL

There will be opportunity to catch up with the team, learn about old and new projects and meet other business, academics and students in the UCL Advances network. We are even paying for the drinks!

We look forward to seeing you there.

Register for the 'UCL Advances 5 years celebration'